1. Subcutaneous Injection Technique
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are delivered via subcutaneous injection — meaning the medication goes into the fatty tissue just beneath the skin, not into muscle or a vein. Proper technique determines both how consistently the drug absorbs and how comfortable the injection feels.
Approved Injection Sites
Injection Angle: 90° vs 45°
The 90-degree perpendicular angle is standard for most adults using 4mm or 5mm pen needles. At this angle, the needle reliably reaches subcutaneous tissue without risk of intramuscular penetration in patients with an adequate fat layer.
A 45-degree angle may be preferable for:
- Lean individuals with minimal subcutaneous fat (BMI under 22)
- Patients using longer 8mm needles
- Children or adolescents on GLP-1 therapy
- Injecting into the thigh when seated (compresses the fat layer)
Using an 8mm needle at 90 degrees on a lean patient risks intramuscular injection, which dramatically alters absorption kinetics and increases injection-site pain.
Site Rotation — Why It Matters
Rotating injection sites within and between the three approved zones prevents lipohypertrophy — a buildup of scar-like fatty tissue caused by repeated needle trauma to the same spot. Lipohypertrophic tissue absorbs GLP-1 medications unpredictably, causing erratic blood levels and blunted efficacy.
Divide each site into a grid. Move at least 1 cm (half an inch) from the previous injection point. Maintain a mental or written log, or use a rotation tracker app. A full rotation through all zones each month is ideal.
Injection Protocol — Step-by-Step
- Wash hands thoroughly with soap and water for 20 seconds. Dry completely.
- Gather supplies: pen, new needle, alcohol swab, sharps disposal container.
- Attach a new needle — remove the paper seal, screw on tightly, then remove both outer and inner needle caps.
- Prime the pen by dialing to the flow check symbol (2 units on insulin pens; follow pen-specific instructions) and pressing until a drop appears at the needle tip.
- Dial your prescribed dose. Confirm the dose window shows the correct number.
- Clean the skin with an alcohol swab. Allow 15–30 seconds for the alcohol to fully evaporate before injecting — wet alcohol stings.
- Pinch (if needed): lean individuals should gently pinch a fold of skin between thumb and forefinger. Most adults with average body composition can inject flat.
- Insert the needle at a 90° angle (or 45° if indicated) with a smooth, swift motion.
- Press and hold the injection button fully down. Count slowly to 6–10 seconds before withdrawing to prevent drug backflow.
- Withdraw the needle at the same angle of insertion. Do not rub the injection site — this can accelerate absorption unpredictably.
- Dispose immediately: recap the outer needle cover, unscrew the needle, and drop it into an FDA-cleared sharps container. Never recap a used needle by hand.
Required for safe needle disposal at home. Puncture-resistant, leak-proof, designed for pen needles. Meets OSHA and EPA guidelines.
As an Amazon Associate, GLP-1 Explained earns from qualifying purchases.
2. Pen Storage: Refrigerator vs. Room Temperature
GLP-1 medications are biological agents sensitive to heat and light degradation. Understanding the difference between storage conditions for unused versus in-use pens is essential to maintaining drug potency.
| Medication | Unused Pen Storage | In-Use Room Temp Window | Max Temp (Room) |
|---|---|---|---|
| Ozempic (semaglutide SC) | 36–46°F / 2–8°C refrigerated | 56 days | 86°F / 30°C |
| Wegovy (semaglutide SC) | 36–46°F / 2–8°C refrigerated | 28 days | 77°F / 25°C |
| Mounjaro (tirzepatide) | 36–46°F / 2–8°C refrigerated | 21 days | 86°F / 30°C |
| Zepbound (tirzepatide) | 36–46°F / 2–8°C refrigerated | 21 days | 86°F / 30°C |
| Victoza (liraglutide) | 36–46°F / 2–8°C refrigerated | 30 days | 77°F / 25°C |
| Saxenda (liraglutide) | 36–46°F / 2–8°C refrigerated | 30 days | 77°F / 25°C |
- Freezing: Never store GLP-1 pens in the freezer. Freezing denatures the protein structure and renders the medication ineffective. Do not use a pen that has been frozen.
- Direct sunlight: Keep pens away from windows and car dashboards. UV exposure degrades the peptide chain.
- Hot cars: Car interiors can exceed 130°F in summer sun — far beyond safe storage limits. Never leave pens in a vehicle.
- Needle left on: Do not store the pen with the needle attached between doses. This pressurizes the cartridge and can cause air bubbles or leakage.
Travel Considerations
When traveling, use an insulated medication travel case (not ice directly against the pen). TSA regulations permit insulin/GLP-1 pens in carry-on luggage without a 3-1-1 limit — bring a letter from your prescriber and keep medications in original packaging. For travel exceeding your room-temperature window, book accommodations with a refrigerator or request a medical mini-fridge through your hotel.
3. Missed Dose Protocol
Weekly GLP-1 injections miss occasionally — life happens. The protocol for what to do depends entirely on how much time has elapsed since the missed dose. The key rule: never double-dose to compensate.
Semaglutide (Ozempic / Wegovy) — Weekly
- Within 5 days of missed dose: Inject the missed dose as soon as you remember. Resume your regular weekly day from that new injection date.
- More than 5 days after missed dose: Skip the missed dose entirely. Do not take it. Resume your regular injection on the next scheduled day.
- Next dose due within 2 days: Skip the missed dose and take the next one as scheduled.
Tirzepatide (Mounjaro / Zepbound) — Weekly
- Within 4 days of missed dose: Inject as soon as remembered. Then resume your original weekly schedule day.
- More than 4 days after missed dose: Skip the missed dose. Inject on the next regularly scheduled day.
- Never inject two doses in the same week.
What Happens to Side Effects After a Missed Dose?
Missing a dose allows GLP-1 receptor sensitivity to partially recover. When you resume — especially at the same dose — some patients experience a temporary return of nausea or GI discomfort. This typically resolves within 24–48 hours. If you miss multiple doses consecutively (illness, supply issues), contact your prescriber — re-titration from a lower dose is sometimes appropriate.
4. Dose Titration Schedules
Every GLP-1 medication begins at a sub-therapeutic "starter" dose and escalates on a structured schedule. This titration period isn't optional or cosmetic — it's the mechanism by which GI tolerance is built and treatment discontinuation rates are minimized.
Semaglutide (Ozempic / Wegovy) Titration
The FDA-approved titration ladder for semaglutide moves in 4-week intervals. Ozempic targets glycemic control (max 2mg); Wegovy targets weight loss (max 2.4mg).
Ozempic: 0.25mg → 0.5mg → 1mg → 2mg (max). Wegovy extends to 2.4mg via 1.7mg bridge dose.
Tirzepatide (Mounjaro / Zepbound) Titration
Tirzepatide's dual GIP/GLP-1 mechanism requires a more granular titration ladder. The 6-step schedule over 20+ weeks represents the most gradual FDA-approved ramp of any current obesity medication.
| Drug | Starting Dose | Max Approved Dose | Titration Schedule | Dosing Frequency |
|---|---|---|---|---|
| Semaglutide (Ozempic) | 0.25mg | 2mg | 0.25 → 0.5 → 1 → 2mg (4-wk steps) | Once weekly |
| Semaglutide (Wegovy) | 0.25mg | 2.4mg | 0.25 → 0.5 → 1 → 1.7 → 2.4mg (4-wk steps) | Once weekly |
| Tirzepatide (Mounjaro) | 2.5mg | 15mg | 2.5 → 5 → 7.5 → 10 → 12.5 → 15mg (4-wk steps) | Once weekly |
| Tirzepatide (Zepbound) | 2.5mg | 15mg | 2.5 → 5 → 7.5 → 10 → 12.5 → 15mg (4-wk steps) | Once weekly |
| Liraglutide (Victoza) | 0.6mg | 1.8mg | 0.6 → 1.2 → 1.8mg (1-wk steps) | Once daily |
| Liraglutide (Saxenda) | 0.6mg | 3mg | 0.6 → 1.2 → 1.8 → 2.4 → 3mg (1-wk steps) | Once daily |
| Dulaglutide (Trulicity) | 0.75mg | 4.5mg | 0.75 → 1.5 → 3 → 4.5mg (4-wk steps) | Once weekly |
5. Why Slow Titration Reduces Nausea — And What Else Helps
Nausea is the most commonly reported side effect of GLP-1 therapy, cited by 20–44% of patients in pivotal trials. Understanding the mechanism explains why titration pace matters so much — and what you can do beyond just waiting it out.
The Mechanism Behind GLP-1 Nausea
GLP-1 receptors are concentrated in the gut, the vagus nerve, and the brainstem area postrema (the brain's "vomiting center"). When GLP-1 activity increases rapidly, it triggers:
- Slowed gastric emptying — food sits in the stomach longer, causing fullness and nausea
- Vagal nerve stimulation — the nerve signals that link gut to brain amplify nausea perception
- Area postrema activation — direct central nervous system signaling that initiates nausea/vomiting reflex
Slow titration allows receptor desensitization to occur gradually. The gut adapts by reducing receptor density and sensitivity over weeks, so the same absolute drug concentration produces progressively less nausea. This is why patients who tolerate 1mg of semaglutide for four weeks rarely experience the same nausea at 2mg that they would have felt if they'd jumped there on week one.
Practical Nausea Mitigation Strategies
- Eat small, low-fat meals. High-fat food slows gastric emptying further — compounding the drug's effect.
- Avoid lying down for 2–3 hours after eating. Reclined position worsens reflux symptoms during delayed gastric emptying.
- Stay hydrated. Dehydration worsens nausea perception and contributes to constipation, another common side effect.
- Time your injection: some patients find weekend injections allow them to rest through peak nausea (typically 24–48 hours post-dose).
- Ginger (tea, capsules) has modest antiemetic evidence and is generally safe alongside GLP-1 therapy.
- If nausea is severe or persistent, ask your prescriber about extending titration steps to 6–8 weeks instead of 4. This is not off-label and is supported by most clinical guidelines.
Injection Site Reactions
Mild localized reactions — redness, itching, or small nodules at the injection site — occur in approximately 5–10% of patients and typically resolve within 24–48 hours. Strategies to minimize them:
- Allow the pen to reach room temperature before injecting (remove from refrigerator 30 minutes early)
- Let the alcohol swab dry completely before injecting
- Rotate sites consistently to prevent lipohypertrophy
- Use the shortest effective needle (4–5mm for most patients)
- Do not rub the site after injection
If you notice a large (>2cm), warm, or painful lump that persists beyond 3–4 days, or if you develop hives, difficulty breathing, or swelling of the face, seek medical attention immediately — these may indicate infection or a hypersensitivity reaction.
Needle Length Selection Guide
| Needle Length | Best For | Angle | Notes |
|---|---|---|---|
| 4mm | Most adults, including people with obesity | 90° | Gold standard for most pen injectors. Reliably subcutaneous in all body types. |
| 5mm | Adults with average to above-average fat layer | 90° | Minimal difference from 4mm. Slightly more room for error in lean individuals. |
| 6mm | Larger individuals, specific site needs | 90° or 45° | May require skin pinch in leaner areas. Not recommended for routine use. |
| 8mm | Legacy devices; less common in modern pens | 45° always | High risk of IM injection at 90°. Use only when prescribed specifically. Requires skin pinch. |
Modern GLP-1 pens (Ozempic FlexPen, Wegovy FlexTouch, Mounjaro KwikPen) use proprietary needle systems. Always use the manufacturer-recommended needle size. Most ship with 4mm needles — confirm before purchasing aftermarket replacements.
Sterile 70% isopropyl alcohol swabs for injection site preparation. Essential for every GLP-1 injection session. Individually wrapped, medical grade.
As an Amazon Associate, GLP-1 Explained earns from qualifying purchases.
Continue Reading
Explore more clinically grounded GLP-1 guides on this site.